Histogen Update - Spencer Kobren Speaks With Dr. Craig L. Ziering
Collapse
X
-
Enrollment of 56 patients with male pattern hair loss in the Phase I/II clinical trial of HSC has been completed, and the trial is ongoing. Dr. Gail Naughton, Histogen CEO and Chairman of the Board, presented the 12 week primary safety and efficacy data at the Society for Investigative Dermatology (SID) Annual Meeting on May 11, 2012.
Sounds like most of the patients were men (http://www.histogen.com/applications/hsc.htm)Comment
-
A little off topic, but technically NW1 is the juvenile hairline, i.e. no hair loss.
"NW0" I guess would be lowering your juvenile hairline beyond where it once was.Like that one stand up comedian who wants his hairline connected to his eyebrows.
Comment
-
Enrollment of 56 patients with male pattern hair loss in the Phase I/II clinical trial of HSC has been completed, and the trial is ongoing. Dr. Gail Naughton, Histogen CEO and Chairman of the Board, presented the 12 week primary safety and efficacy data at the Society for Investigative Dermatology (SID) Annual Meeting on May 11, 2012.
Sounds like most of the patients were men (http://www.histogen.com/applications/hsc.htm)Comment
-
Some observations:
- The Phase I/II was ENTIRELY on men. It says this clearly in the bottom right box "Methods".
- The women are from Ziering's IND trial, and there were ONLY FOUR WOMEN in his trial. So two of those women are shown there - at least 50% had cosmetically significant results. We don't know how the other two went, but they could have been good too.
- The Trichoscan photos are apparently from the men in the Phase I/II.
- I think this may be a STRONG indication that the treatments are indeed compoundable, at least for the first repeat injections. "Results indicate improved efficacy with additional injections."
- S1016 is the most interesting to me because he started with only maybe 40% (at a guess) terminal hair remaining, and ended with about 70%. If this could be repeated on a large scale it could be effectively full coverage for him - AT JUST 3 MONTHS! If he gets better at 12 months (as seems likely) this would have to be considered an effective treatment.
- I am kind of worried that the only results they are posting are those with a significant amount of terminal hair left. Would be interested to see results in someone who has 90% miniaturisation (which is about what I have in my NW 5 zone).
- Total increase in hair count is still only small. 7% in the Pilot study, about 10% in Phase I/II. Further reinforces that HSC is probably best for thickening hair rather than growing new hair.
Conclusion: Fantastic result, but hang on to every hair you can. I am losing confidence that this will work on slick bald scalp at all, and its effectiveness will probably fall off rapidly the greater the degree of miniaturisation.Comment
-
It won't be any different from getting a tattoo. A tattoo is thousands of little injections, injecting a liquid into your skin. This will be exactly the same. It may hurt a bit, but I don't think you'll be caring if it grows your hair back.Comment
-
Comment
-
Comment
-
I just heard about Histogen now and I must say it sounds very promising. Is it realistic to hope for this to be on the market within 5 years time? And is it a one time injection or does it have to be repeated regularly?Comment
Comment